FindTrial
Sign In

A Study to determine the Efficacy of Guduchyadi Yoga in the Management of Medoroga w.s.r. to Dyslipidemia

A Clinical Study to Evaluate the Efficacy of Guduchyadi Yoga in the Management of Medoroga w.s.r. to Dyslipidemia

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/03/040753
Enrollment
30
Registered
2022-03-03
Start date
Unknown
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

Intervention1: Guduchyadi Yoga: Guduchyadi Yoga 6gm twice a day for 90 days Control Intervention1: Tab Rosuvastatin : Tab Rosuvastatin 10 mg once a day for 90 days

Sponsors

self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed and confirmed cases of dyslipidemia. Patients willing to participate for the trial.

Exclusion criteria

Exclusion criteria: Having associated illness such as coronary artery disease, peripheral vascular disease, diabetes mellitus, tuberculosis, renal and liver disorders. Pregnant females and lactating mothers.

Design outcomes

Primary

MeasureTime frame
To evaluate the effect of Guduchyadi Yoga in the management of Medoroga w.s.r. to dyslipidemia.Timepoint: 12 weeks—

Secondary

MeasureTime frame
Assessment of clinical safety of Guduchyadi Yoga in the management of Medoroga w.s.r. to dyslipidemia. Timepoint: 12 weeks—

Countries

India

Contacts

Public ContactDr Sunil Thakur

R.G.G.P.G Ayurvedic College, Paprola

sapnathakur661.st@gmail.com6351562515

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026